Cargando…

Reply: Remarks on the BOADICEA model of genetic susceptibility to breast and ovarian Cancer Research UK

Detalles Bibliográficos
Autores principales:	Antoniou, A C, Pharoah, P D P, Cunningham, A P, Easton, D F
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2005
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361968/ http://dx.doi.org/10.1038/sj.bjc.6602488

Ejemplares similares

The BOADICEA model of genetic susceptibility to breast and ovarian cancer
por: Antoniou, A C, et al.
Publicado: (2004)

Remarks on the BOADICEA model of genetic susceptibility to breast and ovarian cancer
por: van Asperen, C J, et al.
Publicado: (2005)

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions
por: Antoniou, A C, et al.
Publicado: (2008)

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions
por: Antoniou, A C, et al.
Publicado: (2008)

Clinical software development for the Web: lessons learned from the BOADICEA project
por: Cunningham, Alex P, et al.
Publicado: (2012)

Incorporating Truncating Variants in PALB2, CHEK2 and ATM into the BOADICEA Breast Cancer Risk Model
por: Lee, Andrew J., et al.
Publicado: (2016)

BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface
por: Lee, A J, et al.
Publicado: (2014)

BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors
por: Lee, Andrew, et al.
Publicado: (2019)

Correction: BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors
por: Lee, Andrew, et al.
Publicado: (2019)

Use of the BOADICEA Web Application in clinical practice: appraisals by clinicians from various countries
por: Brédart, Anne, et al.
Publicado: (2017)

Incorporating Alternative Polygenic Risk Scores into the BOADICEA Breast Cancer Risk Prediction Model
por: Mavaddat, Nasim, et al.
Publicado: (2023)

Validation of the BOADICEA model for predicting the likelihood of carrying pathogenic variants in eight breast and ovarian cancer susceptibility genes
por: Møller, Nanna Bæk, et al.
Publicado: (2023)

BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families
por: Antoniou, Antonis C, et al.
Publicado: (2006)

Author Correction: Validation of the BOADICEA model for predicting the likelihood of carrying pathogenic variants in eight breast and ovarian cancer susceptibility genes
por: Møller, Nanna Bæk, et al.
Publicado: (2023)

Prospective validation of the BOADICEA multifactorial breast cancer risk prediction model in a large prospective cohort study
por: Yang, Xin, et al.
Publicado: (2022)

Enhancing the BOADICEA cancer risk prediction model to incorporate new data on RAD51C, RAD51D, BARD1 updates to tumour pathology and cancer incidence
por: Lee, Andrew, et al.
Publicado: (2022)

Prospective validation of the breast cancer risk prediction model BOADICEA and a batch-mode version BOADICEACentre
por: MacInnis, R J, et al.
Publicado: (2013)

Reply 2: NICE guidelines on drugs for colorectal cancer
por: Ross, P J, et al.
Publicado: (2003)

Reply: Remarks on sentinel node biopsy in head and neck cancer
por: Hoft, S, et al.
Publicado: (2005)

Reply: The performance of the risk of ovarian malignancy algorithm
por: Van Gorp, T, et al.
Publicado: (2011)

Reply
por: Villaverde, Serena, et al.
Publicado: (2021)

Machine learning techniques for personalized breast cancer risk prediction: comparison with the BCRAT and BOADICEA models
por: Ming, Chang, et al.
Publicado: (2019)

Genetic clinicians' confidence in BOADICEA comprehensive breast cancer risk estimates and counselees' psychosocial outcomes: A prospective study
por: Brédart, Anne, et al.
Publicado: (2022)

Evaluation of the BOADICEA risk assessment model in women with a family history of breast cancer
por: Ståhlbom, Anne Kinhult, et al.
Publicado: (2011)

Streamlining Decision Making in Contralateral Risk-Reducing Mastectomy: Impact of PREDICT and BOADICEA Computations
por: de Silva, Tania Samantha, et al.
Publicado: (2018)

Validation of the BOADICEA model and a 313-variant polygenic risk score for breast cancer risk prediction in a Dutch prospective cohort
por: Lakeman, Inge M. M., et al.
Publicado: (2020)

In Reply
por: Khan, Khurum, et al.
Publicado: (2017)

Emergency in obese patients: a reply to SOBA UK
por: Di Giacinto, Ida, et al.
Publicado: (2022)

Reply: The classification of p53 immunohistochemical staining results and patient outcome in ovarian cancer
por: de Graeff, P, et al.
Publicado: (2007)

Machine learning-based lifetime breast cancer risk reclassification compared with the BOADICEA model: impact on screening recommendations
por: Ming, Chang, et al.
Publicado: (2020)

Dr. Thompson's Reply to the Remarks of Mr. Fogo
por: Thompson, D.
Publicado: (1812)

The genetics of breast and ovarian cancer.
por: Ford, D., et al.
Publicado: (1995)

REPLY
por: Kumar, P.N. Suresh
Publicado: (1999)

Tagging Single Nucleotide Polymorphisms in the BRIP1 Gene and Susceptibility to Breast and Ovarian Cancer
por: Song, Honglin, et al.
Publicado: (2007)

Polygenic susceptibility to prostate and breast cancer: implications for personalised screening
por: Pashayan, N, et al.
Publicado: (2011)

Author's reply
por: Singh, Somesh P, et al.
Publicado: (2014)

Author's Reply
por: Bhalla, Ashu S, et al.
Publicado: (2018)

Reply: ‘Hand pattern indicates risk of prostate cancer’
por: Rahman, A A, et al.
Publicado: (2011)

Reply to the Foregoing "Remarks" of Dr Gairdner
por: Bennett, John Hughes
Publicado: (1857)

Authors' reply
por: Kalikar, M.V., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_4bhli8gvnfo7ti0ea0hqsgke7t